In His BloodUniversity of New Mexico Comprehensive Cancer Center
A former fellow at the UNM Comprehensive Cancer Center, Dr. Shashank Cingam comes back to New Mexico to Treat blood cancers.
A former fellow at the UNM Comprehensive Cancer Center, Dr. Shashank Cingam comes back to New Mexico to Treat blood cancers.
Dr. Colleen McCormick joins the University of New Mexico Comprehensive Cancer Center. Her curiosity and desire to work with patients from the beginning of their diagnosis to the end of their care led her to gynecologic oncology.
The human papillomavirus (HPV) vaccine is safe and effective – but it’s not for everyone. Michelle Ozbun, PhD, and her team at UNM Cancer Center published a research article earlier this year in Antimicrobial Agents and Chemotherapy in which they describe how a drug called protamine sulfate blocks HPV infection. Like a game of musical chairs among molecules, the drug molecules bind to heparan sulfate cell receptors, preventing HPV virus particles from doing so.
Kimberly Leslie, MD, was awarded a four-year, $1.8 million grant from the Department of Defense (DOD) to further study high-risk uterine cancer. Her research has led her to study the differences between natural progesterone and synthetic progestins – hormones often used for birth control – and the influence of progesterone on a tumor suppressor protein called p53. The hormones, drugs and proteins, she’s learned, influence each other and the body’s cells in complex ways.
Cheryl Sampson has close to 25 years in health care research administration experience at both a university cancer center and in the health system setting. It gives her a unique combination of experience that suits the unique nature of the job in New Mexico.
“I think for me, what I find most interesting about rectal cancer is the multidisciplinary and individualized care and a new trend in treatment to offer organ preservation instead of surgery in selected patients,” she said. “I love surgery, but I also know the consequences of doing surgery. I saw UNM was also interested in this treatment strategy that might be more beneficial for some patients and I wanted to be in a cancer center where I could offer that approach.”
This assistance is highly important. It ultimately affects some patients who might not otherwise be successful with treatment if they are constantly stressed with having to find the means to stay here or get here.
Bladder cancer affects nearly 84,000 people in the United States each year, making it the sixth most common cancer. Most people survive it, but unfortunately, many lose their bladders. Neda Hashemi, MD, and her team at The University of New Mexico Comprehensive Cancer Center are now offering several clinical trials, including one that will give people with bladder cancer a chance to fight their disease and keep their bladders.
With all that the Land of Enchantment has to offer, skin cancer isn’t on the top on anyone’s list. But abundant sunshine and a dearth of dermatologists in the state pose a challenge for detecting and treating the various forms of skin cancer. Skin Cancer Screening clinics are now resuming. The first of several new clinics will be held in Albuquerque on Saturday, May 7. More are planned over the coming year in Gallup, Taos and southern New Mexico.
Kelly Dunn recently became board certified by the Academy of Nutrition and Dietetics in Oncology Nutrition.
The UNM Comprehensive Cancer Center has opened the Targeted Agent and Profiling Utilization Registry (TAPURTM) Study, sponsored by the American Society of Clinical Oncology (ASCO). The clinical trial is cancer agnostic. It may help people who have rare cancer mutations and enable them to receive personalized cancer therapy.
Alissa Greenbaum, MD, took a winding path through medicine to land in surgical oncology and lead the University of New Mexico Comprehensive Cancer Center's Peritoneal Surface Malignancy and HIPEC program.
The UNM Comprehensive Cancer Center's team of pharmacists is involved in every aspect of patient care. From preparing complicated drugs to helping patients find a way to pay for them.
Mariah Candelaria is a three-time survivor of Hodgkin Lymphoma and received a stem cell transplant at the University of New Mexico Comprehensive Cancer Center. During and after her recovery she's leaned on dance to make it through. Now she wants to give back to others who are going through similar challenges fighting cancer.
The University of New Mexico Comprehensive Cancer Center has once again been awarded the highest designation and rating in the United States for cancer treatment and research programs.
The UNM Comprehensive Cancer Center helps patients with high-complexity cases. Elyse Eckart's experience with breast cancer has led her to take on new challenges and embrace tasks and activities she may not have before. She's also giving back to the community.
Like a mystery detective, Sara G.M. Piccirillo, PhD, is hunting deadly bad actors by studying the crime scene and questioning bystanders one by one. But these bad actors are cells in the brain. She is using two grants to study tumor cells and cells in the surrounding area, one by one.
UNM Comprehensive Cancer Center conducted a two-pronged study looking into the efficacy of 3D mammograms and also the general awareness of the technology among at-risk populations in New Mexico. The study was conducted prior to the technology gaining more use among the public, and showed fewer callbacks and more awareness even in its early days.
The University of New Mexico Comprehensive Cancer Center is using a grant from the American Cancer Society to introduce more underrepresented minority undergraduate students to cancer research
The UNM Comprehensive Cancer Center's orthopedic oncology program helped Kyle Stepp recover from bone cancer and lead an active and generous life.
Dr. Kinjyo's work Will continue to look at how combining different drug treatments can improve outcomes for women with ovarian cancer.
Michelle Ozbun, PhD, and her team developed a way to measure how many infectious human papillomavirus particles are left on a surface after it has been disinfected. They found that disinfectants approved for use on medical devices work well, and they recently published their work online in The Lancet journal EBioMedicine.
Experienced radiation oncologist Cherie Hayostek, MD, joins the team at the University of New Mexico Comprehensive Cancer Center in Albuquerque, NM.
Ben Ferguson joins the UNM Comprehensive Cancer Center as surgical oncologist. It was the complexity of cancer care that drew him to the specialty and the resources of a comprehensive cancer center that drew him to UNM.
Stewart Livsie is the UNM Comprehensive Cancer Center's manager of maintenance and construction and was honored by the IFMA recently. He was instrumental in securing necessary PPE and other supplies to ensure the UNM Cancer Center remains operational during COVID-19 restrictions. He's also overseen multimillion dollar expansions to the center.
Itzhak Nir, MD, named first-ever Elsie P. Barry/Cowboys for Cancer Research Endowed Professor in Hepato-Pancreatico-Biliary and Oncology Surgery at The University of New Mexico Comprehensive Cancer Center. Cowboys for Cancer Research has been a longtime supporter of the UNM Comprehensive Cancer Center and is committed to addressing New Mexico’s most important cancer challenges through funding research initiatives and creating endowed professorships.
Fahy named one of 10 endowed professors created by the Surface Family Trust. Fahy has been with UNM since July 2013 when she was an associate professor of Surgical Oncology. In 2015, she was named associate professor of Internal Medicine in the Division of Palliative Medicine.
Our DNA acts like a book of recipes for making proteins. But if a recipe is wrong, what does a cell do Peng Mao, PhD, and his team discovered an intricate series of events that cells use to repair our DNA as the recipes are being read. Their findings could lead to improved cancer treatments.
Liquid biopsies hold promise of finding cancer in blood before they can form new tumors
Ala Ebaid, MD, completed his fellowship in hematology/oncology at the UNM Cancer Center in June and begins clinical work in August. He's been in New Mexico for a decade, and he says he doesn't plan to leave any time soon.
A quintessential part of facing any kind of challenge is reaping the rewards when you’ve successfully met it. It’s an adage that can be applied to nearly any profession, including surgical oncology, and it’s what brought Vinay Rai, MD, FACS, FASCRS, to the UNM Comprehensive Cancer Center.
Ivan Piñón, MD, once thought his future would lead to the lab bench. But a long career practicing as an endocrinologist has led him to the UNM Comprehensive Cancer Center to serve as a crucial part of the effort to build a thyroid and parathyroid center of excellence.
Chuck Wiggins, PhD, Director of the New Mexico Tumor Registry, was recently honored by the North American Association of Central Cancer Registries with its Calum S. Muir Memorial Award.
This year, the Lobo Cancer Challenge is meeting the challenge of a global pandemic by holding the event virtually on Saturday, Sept. 19. Far from a limitation, a virtual event will give participants the opportunity to set new courses, find different routes, and ride along different trails, all to raise critical funds for New Mexico’s fight against cancer.
Some people must make the difficult decision whether to put food on the table or spend money on other necessities, such as a utility bill or rent. In a recently published paper, Jean McDougall, PhD, and colleagues report the results of a 400-person survey that assesses food insecurity before and after cancer diagnosis
David Peabody, PhD, and Bryce Chackerian, PhD, are creating vaccines from particles that are the opposite of Trojan Horses: they look deadly on the outside but are harmless on the inside. Their virus-like particles may rouse the immune system into combatting COVID-19. The idea is to trick the body into believing it’s been infected with a microscopic foe.
Polly’s Run is on a mission to end pancreatic cancer. The annual fundraiser is held each year in honor of Polly Rogers, whose best friends and three sons started the 5K run-walk event after she died in 2009. This year, the event will be held virtually.
For Erika Maestas, MD, the journey to UNM Cancer Center is a journey home. Maestas grew up in Albuquerque, while her parents hailed from rural northern New Mexico. She likes that the UNM Cancer Center’s cutting edge research into cancer treatments gives her a chance to continue learning while continuing to do what she loves: working with patients
When the thyroid and parathyroid glands don’t work well, the entire body feels out of balance. To tackle thyroid and parathyroid diseases, Nathan Boyd, MD, recently launched the UNM Thyroid and Parathyroid Surgery Program, housed at the UNM Comprehensive Cancer Center, to offer state-of-the-art treatments for these diseases.
Doctors face a difficult decision when they must choose a drug combination that will benefit the person sitting before them in an exam room. Statistics can’t show how any one person will respond to a reatment.works in people. Dr. Sarah Adams is using a $1.2M to find better ways to predict which women will benefit from her drug combination, now in clinical trials.
To mark National Cancer Prevention Month, The University of New Mexico Men’s and Women’s basketball teams hope to pack the house with pink in coming weeks in honor of breast cancer survivors and fighters.
The UNM Department of Dermatology and the UNM Comprehensive Cancer Center are hosting free skin cancer screenings around the state to address the state's dermatologist shortage. The next screening clinic will take place in Taos, N.M., on Feb. 29.
Cervical cancer is the third most common cancer in women worldwide, but most American women can prevent it by being screened on time with tests that detect human papillomaviruses (HPV). A new study led UNM Comprehensive Cancer Center scientists shows that screening every three years instead of annually prevents most cervical cancers.
Cancer-fighting compound fights obesity and diabetes: Eric Prossnitz, PhD, and his team reported that G-1, a cancer-fighting compound they discovered some years ago, reduces fat in obese mice. Although G-1 is currently in phase 1 clinical trials for cancer, Prossnitz and his team are planning preclinical studies to use G-1 to fight fat in obese people.
The Southwest Harvest for Health pilot study pairs cancer survivors with local master gardeners who have been trained in gardening techniques that address New Mexico’s growing challenges. The pair will create a vegetable garden at the survivor’s home .
At the end of each legislative session, New Mexico’s senators and representatives lace up to play a hotly-contested basketball game. No one officially tracks how many games each team has won — or any other statistics — because, in the end, the real winners are New Mexicans who face cancer.
Sara Piccirillo, PhD, is passionate about finding a way to beat glioblastoma, the most aggressive type of brain cancer. Her research focuses on a feature of glioblastoma tumors that appears to be the source of their strength: the extreme differences among their tumor cells.
Eric Prossnitz, PhD, and his team have recently completed studies on a compound that they think could be made to attack breast cancer cells differently than current drugs. Their work is reported in the November online issue of Cell Chemical Biology. This newly discovered behavior could turn the chemical into potent breast cancer drugs
UNM Athletics and UNM Cancer Center sponsor football game to celebrate all women battling breast cancer
Breast medical oncologist Ursa Brown-Glaberman, MD, wants to catch life-threatening breast cancers earlier, when these women have many more treatment choices and a much better chance of beating the disease. She leads the TMIST study at the UNM Cancer Cancer. The study compares tomosynthesis with 2-dimensional digital mammography for breast cancer screening.